Abstract
The Australian HIV-infected (HIV+) population is largely comprised of high-functioning men who have sex with men (MSM). Like other English-speaking countries, Australia mostly relies on US neuropsychological normative standards to detect and determine the prevalence of neurological disorders. Whether the US neuropsychological (NP) normative standards are appropriate in Australian HIV+ MSM has not been established. Ninety virally suppressed HIV+ and 49 HIV-uninfected (HIV−) men (respectively 86 and 85 % self-reported MSM; mean age 54 and 56 years, mean premorbid verbal IQ estimate 110 and 111) undertook standard NP testing. The raw neuropsychological data were transformed using the following: (1) US standards as uncorrected scaled scores and demographically corrected T scores (US norms); and (2) z scores (without demographic corrections) derived from Australian comparison group scaled scores (local norms). To determine HIV-associated neurocognitive disorder prevalence, we used a standard definition of impairment based upon a battery-wide summary score: the global deficit score (GDS). Impairment classification (GDS ≥ 0.5) based on the local norms was best at discriminating between the two groups (HIV− = 14.3 % vs. HIV+ = 53.3 %; p < 0.0001). This definition was significantly associated with age. Impairment classification based on the US norms yielded much lower impairment rate regardless of the HIV status (HIV− = 4.1 % vs. HIV+ = 14.7 %; p = 0.05), but was associated with historical AIDS, and not age. Both types of summary scores were associated with reduced independence in activities of daily living (p ≤ 0.03). Accurate neuropsychological classifications of high (or low) functioning individuals may need country-specific norms that correct for performance-based (e.g., reading) estimates of premorbid cognition in addition to the traditional demographic factors.
Similar content being viewed by others
References
Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69:1789–1799
Australian Neuroscience Society (2010) Australian health & medical research funding summary. http://www.ans.org.au/uploads/documents/ANSweb_A&NZResearch%20funding.pdf
Blackstone K, Moore DJ, Franklin DR, Clifford DB, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, Ellis RJ, Atkinson JH, Grant I, Heaton RK (2012) Defining neurocognitive impairment in HIV: deficit scores versus clinical ratings. Clin Neuropsychol 26:894–908
Brandt J, Benedict RH (2001) Hopkins verbal learning test-revised. Professional manual. Psychological Assessment Resources, Inc., Lutz
Carey CL, Woods SP, Gonzalez R, Conover E, Marcotte TD, Grant I, Heaton RK (2004) Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J Clin Exp Neuropsychol 26:307–319
Cohen J, Cohen P (1983) Applied multiple regression/correlation analysis for the behavioral sciences. Erlbaum: Hillsdale, NJ
Cole MA, Margolick JB, Cox C, Li X, Selnes OA, Martin EM, Becker JT, Aronow HA, Cohen B, Sacktor N, Miller EN (2007) Longitudinally preserved psychomotor performance in long-term asymptomatic HIV-infected individuals. Neurology 69:2213–2220
Cysique LA, Brew BJ (2011) Prevalence of non-confounded HIV-associated neurocognitive impairment in the context of plasma HIV RNA suppression. J Neurovirol 17:176–83
Cysique LA, Moffat K, Moore DM, Lane TA, Davies NW, Carr A, Brew BJ, Rae C (2013) HIV, vascular and aging injuries in the brain of clinically stable HIV-infected adults: a (1)H MRS study. PLoS One 8:e61738
D’Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB (2008) General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 117:743–753
Friis-Moller N, Thiebaut R, Reiss P, Weber R, Monforte AD, De Wit S, El-Sadr W, Fontas E, Worm S, Kirk O, Phillips A, Sabin CA, Lundgren JD, Law MG (2010) Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study. Eur J Cardiovasc Prev Rehabil 17:491–501
Garvey L, Surendrakumar V, Winston A (2011) Low rates of neurocognitive impairment are observed in neuro-asymptomatic HIV-infected subjects on effective antiretroviral therapy. HIV Clin Trials 12:333–338
Green A, Garrick T, Sheedy D, Blake H, Shores A, Harper C (2008) Repeatable battery for the assessment of neuropsychological status (RBANS): preliminary Australian normative data. Aust J Psychol 60:72–79
Heaton RK, Marcotte TD, Mindt MR, Sadek J, Moore DJ, Bentley H, McCutchan JA, Reicks C, Grant I (2004a) The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc 10:317–331
Heaton RK, Miller SW, Taylor MJ, Grant I (2004b) Revised comprehensive norms for an expanded Halstead-Reitan Battery: demographically adjusted neuropsychological norms for African American and Caucasian adults Scoring Program. Psychological Assessment Resources, Odessa
Heaton RK, Clifford DB, Franklin DR Jr, Woods SP, Ake C, Vaida F, Ellis RJ, Letendre SL, Marcotte TD, Atkinson JH, Rivera-Mindt M, Vigil OR, Taylor MJ, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 75:2087–2096
Joseph J, Achim CL, Boivin MJ, Brew BJ, Clifford DB, Colosi DA, Ellis RJ, Heaton RK, Gallo-Diop A, Grant I, Kanmogne GD, Kumar M, Letendre S, Marcotte TD, Nath A, Pardo CA, Paul RH, Pulliam L, Robertson K, Royal W 3rd, Sacktor N, Sithinamsuwan P, Smith DM, Valcour V, Wigdahl B, Wood C (2013) Global NeuroAIDS roundtable. J Neurovirol 19:1–9
Kamminga J, Cysique LA, Lu G, Batchelor J, Brew BJ (2013) Validity of cognitive screens for HIV-associated neurocognitive disorder: a systematic review and an informed screen selection guide. Curr HIV/AIDS Rep 10:342–55
Lane TA, Moore DM, Batchelor J, Brew BJ, Cysique LA (2012) Facial emotional processing in HIV infection: relation to neurocognitive and neuropsychiatric status. Neuropsychology 26:713–722
Law MG, Woolley I, Templeton DJ, Roth N, Chuah J, Mulhall B, Canavan P, McManus H, Cooper DA, Petoumenos K (2011) Trends in detectable viral load by calendar year in the Australian HIV observational database. J Int AIDS Soc 14:10
Letendre S (2011) Central nervous system complications in HIV disease: HIV-associated neurocognitive disorder. Top Antivir Med 19:137–142
Lipsey M, Wilson D (2001) Practical meta-analysis. Sage Publications, London
Manly JJ, Byrd DA, Touradji P, Stern Y (2004) Acculturation, reading level, and neuropsychological test performance among African American elders. Appl Neuropsychol 11:37–46
Mitrushina M, Boone KB, Razani J, D’Elia LF (2005) Handbook of normative data for neuropsychological assessment, 2nd edn. Oxford University Press, Oxford
Munoz-Moreno JA, Fumaz CR, Ferrer MJ, Prats A, Negredo E, Garolera M, Perez-Alvarez N, Molto J, Gomez G, Clotet B (2008) Nadir CD4 cell count predicts neurocognitive impairment in HIV-infected patients. AIDS Res Hum Retrovir 24:1301–1307
Nelson H, Willison J (1991). National Adult Reading Test (NART). Test manual, 2nd edn. NFER-NELSON: Windsor, UK
Sacktor N, McDermott MP, Marder K, Schifitto G, Selnes OA, McArthur JC, Stern Y, Albert S, Palumbo D, Kieburtz K, De Marcaida JA, Cohen B, Epstein L (2002) HIV-associated cognitive impairment before and after the advent of combination therapy. J Neurovirol 8:136–142
Simioni S, Cavassini M, Annoni JM, Rimbault Abraham A, Bourquin I, Schiffer V, Calmy A, Chave JP, Giacobini E, Hirschel B, Du Pasquier RA (2010) Cognitive dysfunction in HIV patients despite long-standing suppression of viremia. AIDS 24:1243–1250
Strauss E, Sherman EMS, Spreen O (2006) A compendium of neuropsychological tests: administration, norms, and commentary. Oxford University Press, Oxford
Sullivan R, Senior G, Henessy M (2000) Regression equations: Australian age-education and premorbid cognitive/intellectual estimates for the WAIS-III In: Assessment Psychology Online: http://www.assessmentpsychology.com/iq-estimates-3.htm
Taylor MJ, Heaton RK (2001) Sensitivity and specificity of WAIS-III/WMS-III demographically corrected factor scores in neuropsychological assessment. J Int Neuropsychol Soc 7:867–874
The Kirby Institute (2012) HIV, viral hepatitis and sexually transmissible infections in Australia annual surveillance report 2012. In: Institute TK (ed) The University of New South Wales, Sydney, NSW 2052
The Kirby Institute (2013) HIV, viral hepatitis and sexually transmissible infections in Australia annual surveillance report 2013. In: Institute TK (ed) The University of New South Wales, Sydney, NSW 2052
UNAIDS (2012) UNAIDS Report on the global AIDS epidemic 2012. WHO: (Digital version)
Williams JM, Cottle CC (2011) A correction for recruitment bias in norms derived from meta-analysis. Psychol Assess 23:856–864
Winston A, Arenas-Pinto A, Stohr W, Fisher M, Orkin CM, Aderogba K, De Burgh-Thomas A, O’Farrell N, Lacey CJ, Leen C, Dunn D, Paton NI (2013) Neurocognitive function in HIV infected patients on antiretroviral therapy. PLoS One 8:e61949
Woods SP, Moore DJ, Weber E, Grant I (2009) Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychol Rev 19:152–168
Wright EJ, Grund B, Robertson K, Brew BJ, Roediger M, Bain MP, Drummond F, Vjecha MJ, Hoy J, Miller C, Penalva de Oliveira AC, Pumpradit W, Shlay JC, El-Sadr W, Price RW (2010) Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons. Neurology 75: 864–73
Acknowledgments
We would like to thank Dr. Mark Bloch, director of the Holdsworth House General Practice for facilitating the co-enrolment of his HIV− cohort into the HIV and aging cohort. We would also like to thank the HIV physicians and the nursing staff at the Immunology and Infectious Diseases Department of St. Vincent’s Hospital for their support and investment in the study. Last but not least, we would like to give a special thanks to all our participants for their time and involvement in the project.
Conflict of interest
Lucette A. Cysique: This study was supported by the National Health and Medical Research Council of Australia project grant ID568746 (Cysique CIA/PI), the 2009–2012 postdoctoral Brain Science UNSW fellowship (Cysique), 2012 Mercks Sharp Dome (MSD) partial salary support for 2012, the National Health and Medical Research Council of Australia Career Development Fellowship APP1045400 (Cysique CIA/PI), and the Peter Duncan Neurosciences Unit (Head Prof. Bruce Brew). MSD had no direct participation in the current study design, data analyses, and interpretation. Dr. Cysique has otherwise no conflict of interest with the organizations that funded this research. Robert K. Heaton, Jody Kamminga, Tammy Lane, Thomas M. Gates, Danielle M. Moore, and Emma Hubner have no conflict of interest with the organizations that funded this research. Andrew Carr has received grants from the National Health and Medical Research Council of Australia, has received research funding, consultancy fees, lecture and travel sponsorships from MSD, and has served on advisory boards for MSD. Bruce J. Brew has received grants from the National Health and Medical Research Council of Australia, had received payment as board member for MSD, and received travel/accommodation expenses covered or reimbursed by MSD.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
(PDF 214 kb)
Rights and permissions
About this article
Cite this article
Cysique, L.A., Heaton, R.K., Kamminga, J. et al. HIV-associated neurocognitive disorder in Australia: a case of a high-functioning and optimally treated cohort and implications for international neuroHIV research. J. Neurovirol. 20, 258–268 (2014). https://doi.org/10.1007/s13365-014-0242-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13365-014-0242-x